Company Overview
Snapshot
Founded in November 2019 by Dr. Or Peleg and Barry (Boris) Loevsky, LiteBC operates with 11–50 employees. The company has secured funding across 5 rounds from 3 investors, with IN Venture leading a round in January 2025. LiteBC is currently in the clinical trial stage for its noninvasive blood count device.
Business overview
LiteBC is a Health Tech & Life Sciences company developing a noninvasive blood count device designed for real-time, in-vivo monitoring of blood cells. Its core technology utilizes advanced imaging with multiple channels to analyze vital blood parameters, including white blood cells, red blood cells, differential counts, relative red blood cell volume, and hemoglobin. The device, which involves placing a handheld optical probe on a patient's lip, aims to transform complete blood counts into a simple and accessible test, serving the medical devices and digital healthcare sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is the current product stage of LiteBC's technology?
- LiteBC's product, HemoScope, is currently in the clinical trial stage, aiming to transform complete blood counts into a simple and accessible test.